Immunology

Urinary Progesterone-Induced Blocking Factor Concentration Is Related to Pregnancy Outcome

Abstract
Peripheral lymphocytes from healthy pregnant women secrete a mediator protein named the Progesterone Induced Blocking Factor (PIBF) that exerts an immunomodulatory function, and contributes to the maintenance of pregnancy in mice. The gene coding for PIBF mRNA has been cloned and sequenced, and now the recombinant human protein is available. The aim of this study was to develop an ELISA test for determining PIBF concentrations in biological samples of pregnant women. We determined urinary PIBF concentrations of 86 healthy non-pregnant individuals and from almost 500 pregnant women by ELISA. During normal pregnancy the concentration of PIBF continuously increased until the 37th gestational weeks, and was followed by a sharp decrease after the 41st week of gestation. In pathological pregnancies urinary PIBF levels failed to increase. The onset of labour was predictable on the basis of this test, whether it was term or pre-term delivery. In urine of patients with pre-eclampsia PIBF concentrations were significantly lower than in normal pregnancy, and showed a correlation with the number of symptoms presented. These data, in line with previous in vivo findings suggest that PIBF production is a characteristic feature of normal pregnancy, and determination of PIBF concentration in urine might be of use for the diagnosis of threatened premature pregnancy termination.

Key words: Immunology • Pregnancy • Progesterone

This article has been cited by other articles:

				R. G Lea and O. Sandra Immunoendocrine aspects of endometrial function and implantation Reproduction, September 1, 2007; 134(3): 389 - 404. [Abstract] [Full Text] [PDF]